Literature DB >> 25460194

In-vitro activity of taurolidine on single species and a multispecies population associated with periodontitis.

Lilly Zollinger1, Simone Schnyder1, Sandor Nietzsche2, Anton Sculean1, Sigrun Eick3.   

Abstract

The antimicrobial activity of taurolidine was compared with minocycline against microbial species associated with periodontitis (four single strains and a 12-species mixture). Minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs), killing as well as activities on established and forming single-species biofilms and a 12-species biofilm were determined. The MICs of taurolidine against single species were always 0.31 mg/ml, the MBCs were 0.64 mg/ml. The used mixed microbiota was less sensitive to taurolidine, MIC and the MBC was 2.5 mg/ml. The strains and the mixture were completely killed by 2.5 mg/ml taurolidine, whereas 256 μg/ml minocycline reduced the bacterial counts of the mixture by 5 log10 colony forming units (cfu). Coating the surface with 10 mg/ml taurolidine or 256 μg/ml minocycline prevented completely biofilm formation of Porphyromonas gingivalis ATCC 33277 but not of Aggregatibacter actinomycetemcomitans Y4 and the mixture. On 4.5 d old biofilms, taurolidine acted concentration dependent with a reduction by 5 log10 cfu (P. gingivalis ATCC 33277) and 7 log10 cfu (A. actinomycetemcomitans Y4) when applying 10 mg/ml. Minocycline decreased the cfu counts by 1-2 log10 cfu independent of the used concentration. The reduction of the cfu counts in the 4.5 d old multi-species biofilms was about 3 log10 cfu after application of any minocycline concentration and after using 10 mg/ml taurolidine. Taurolidine is active against species associated with periodontitis, even within biofilms. Nevertheless a complete elimination of complex biofilms by taurolidine seems to be impossible and underlines the importance of a mechanical removal of biofilms prior to application of taurolidine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biofilm; Minocycline; Periodontal pathogens; Taurolidine

Mesh:

Substances:

Year:  2014        PMID: 25460194     DOI: 10.1016/j.anaerobe.2014.11.008

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  7 in total

1.  Novel multifunctional dental bonding agent for Class-V restorations to inhibit periodontal biofilms.

Authors:  Lin Wang; Chunyan Li; Michael D Weir; Ke Zhang; Yanmin Zhou; Hockin H K Xu; Mark A Reynolds
Journal:  RSC Adv       Date:  2017-06-02       Impact factor: 3.361

2.  In vitro activity of taurolidine gel on bacteria associated with periodontitis.

Authors:  Sigrun Eick; Nicoletta Gloor; Cecilia Püls; Jürg Zumbrunn; Anton Sculean
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

3.  Activity of taurolidine gels on ex vivo periodontal biofilm.

Authors:  Luca Pirracchio; Aline Joos; Nina Luder; Anton Sculean; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2017-12-14       Impact factor: 3.573

4.  Taurolidine Acts on Bacterial Virulence Factors and Does Not Induce Resistance in Periodontitis-Associated Bacteria-An In-Vitro Study.

Authors:  Sabrina Radakovic; Nicola Andreoli; Simon Schmid; Sandor Nietzsche; Jürg Zumbrunn; Anton Sculean; Sigrun Eick
Journal:  Antibiotics (Basel)       Date:  2020-04-07

5.  EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence In Vitro-Impairment of Secretory Profile and Biofilm Production onto Peritoneal Dialysis Catheters.

Authors:  Bruna Colombari; Gaetano Alfano; Christian Gamberini; Gianni Cappelli; Elisabetta Blasi
Journal:  Microbiol Spectr       Date:  2021-11-17

6.  The In-Vitro Activity of a Cold Atmospheric Plasma Device Utilizing Ambient Air against Bacteria and Biofilms Associated with Periodontal or Peri-Implant Diseases.

Authors:  Gert Jungbauer; Leandro Favaro; Steffen Müller; Anton Sculean; Sigrun Eick
Journal:  Antibiotics (Basel)       Date:  2022-05-31

7.  Effect of mouthwashes on the composition and metabolic activity of oral biofilms grown in vitro.

Authors:  Mercedes Fernandez Y Mostajo; Rob A M Exterkate; Mark J Buijs; Wim Crielaard; Egija Zaura
Journal:  Clin Oral Investig       Date:  2016-06-23       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.